Skip to content
Start your journey

Active surveillance: being watched instead of treated

Living with a cancer that is being monitored rather than treated — why it is offered, what the monitoring involves, and how people cope with knowing it is still there.

6 min read · Part of Follow-Up & Surveillance

Written by The LifeAfterward editorial team from the sources listed at the end of this page.

Not individually reviewed by a clinician. This page is written from published clinical guidance, listed in full at the end, and is general information rather than medical advice — your own team knows your case. See our editorial standards.

Last checked against its sources · Last updated · Next check due

In short

  • Active surveillance is a treatment decision, not a waiting list. It is chosen because treating now would cause more harm than benefit.
  • It involves a defined schedule of tests, with agreed triggers for switching to treatment.
  • For low-risk prostate cancer in particular, long-term survival on surveillance is excellent, which is why it is recommended rather than tolerated.
  • The hardest part is usually psychological, and that is a recognised part of it rather than a personal failing.

What this means

Your team has judged that your cancer is growing slowly enough, or is small enough, that treating it immediately would expose you to real harms — incontinence, sexual dysfunction, surgical risk — to prevent something that may never cause you a problem. So instead they watch it closely, with a plan to treat if it changes. You are not being denied treatment or left to it. You are on a monitoring protocol with defined rules.

This is not doing nothing

The name does most of the damage. *Watchful waiting* and *active surveillance* both sound like an absence of care, and people commonly report feeling they have been put to one side. In practice active surveillance is more intensive monitoring than most treated patients receive.

It exists because of a genuine finding in cancer medicine: some cancers, particularly low-grade prostate cancer, grow so slowly that most people who have them die with them rather than of them. Treating every one of those would mean subjecting large numbers of people to lasting side effects for no gain.

Active surveillance and watchful waiting are not the same thing

Active surveillance monitors closely with the intention of curative treatment if things change. Watchful waiting is usually used where someone would not be fit for or would not want radical treatment, and monitors for symptoms in order to manage them. If you are not sure which you are on, that is an important question to ask directly.

What the monitoring actually involves

The schedule depends entirely on the cancer. What every good surveillance plan shares is that it is written down, it is regular, and it has explicit triggers for changing course.

  • Regular blood tests where a marker exists — PSA in prostate cancer is the most familiar example.
  • Scheduled imaging, such as MRI, at set intervals rather than in response to worry.
  • Repeat biopsies at defined points for some cancers, to check the grade has not changed.
  • Clinical review, where someone examines you and asks about symptoms.
  • Agreed thresholds — a rate of change, a grade, a size — that would move you to treatment.

Make sure you know

  • Exactly which tests you are having and how often.
  • What specific result would trigger a change of plan.
  • Who is responsible for booking each test, and what happens if one is missed.
  • How and when you will be told results — and whether no news means good news.
  • What symptoms should prompt you to make contact between appointments.
  • Whether you can change your mind and ask for treatment.

The last one matters. Choosing surveillance is not irreversible, and preferences legitimately change over time.

Living with knowing it is there

This is the part clinicians under-discuss and patients find hardest. You have been told you have cancer, and then told the plan is to leave it alone. Many people describe a low background hum of unease that spikes sharply around test dates.

  • Anxiety before tests is near-universal and tends to settle into a pattern people learn to anticipate — see coping with scan anxiety.
  • Some people find detail reassuring and want every number; others find it feeds rumination. Both are legitimate, and you can tell your team which you are.
  • Booking appointments early in the day and asking for results promptly shortens the waiting, which is usually the worst part.
  • Partners and family often carry this badly too, particularly if they think the correct response is to be relentlessly positive.

Anxiety is not a reason to be treated, but it is a reason to be helped

Some people do choose treatment because living with monitoring is intolerable, and that is a valid decision made with a team. But distress on surveillance is treatable in its own right — psychological support for exactly this is well established. Ask for it before concluding that surgery is the only way to stop feeling like this.

Not falling out of the system

Surveillance depends on the appointments actually happening, across years, often through changes of consultant, hospital system and address. People do drift out of it, and the consequences are real.

  1. Keep your own record of every test and result, rather than relying on being recalled.
  2. Diarise the next appointment as soon as you leave the last one, and chase it if it does not arrive.
  3. Tell your family doctor you are on active surveillance so it is in your primary care record.
  4. If you move or change hospital, ask explicitly for the surveillance protocol to be transferred.
  5. If you have dropped out, go back. Re-entering monitoring is a normal request, not an awkward one.

The My Journey section of this site keeps appointments, questions and results on your own device if you want somewhere to hold them.

What to ask your healthcare team

  • Am I on active surveillance or watchful waiting, and what is the difference in my case?
  • What exactly is the monitoring schedule, and for how long does it continue?
  • What result or change would mean moving to treatment?
  • What are the risks of waiting, in numbers, compared with treating now?
  • Who books each test, and how will I get the results?
  • What symptoms should make me contact you between appointments?
  • If I decide I want treatment instead, is that still an option later?

Save questions to My Journey so you have them in the room, or use a ready-made list.

When to seek medical advice

Between scheduled appointments, these are worth raising rather than saving up.

Contact your healthcare team if you have:

  • Any new or changing symptom related to the area being monitored.
  • A scheduled test or appointment that has not arrived when it should have.
  • Results you have not been given, where you were expecting them.
  • Anxiety that is affecting your sleep, work or relationships.
  • A feeling that you want to reconsider the plan — that is a conversation, not a failure.

If you are worried and unsure, contact your team anyway — they would far rather hear from you unnecessarily than late. What to do in an emergency.

Common questions

Is active surveillance safe?

For carefully selected low-risk cancers it is, and for low-risk prostate cancer long-term outcomes on surveillance are excellent. Safety depends on the monitoring actually happening on schedule, which is why keeping your own record matters.

Can I change my mind and have treatment?

In most cases yes. Active surveillance is chosen with the intention that curative treatment remains available. Preferences change, and that is a conversation to have with your team rather than a decision you are locked into.

Why would a doctor not treat a cancer they have found?

Because treatment carries certain harms and this cancer may carry very little risk. Where a cancer grows slowly enough that it is unlikely to cause problems in your lifetime, treating it immediately can cost you far more than it saves.

Sources

This page was written from the guidance below and checked against it on . Links are re-checked at each review — see our editorial standards.

  1. National Cancer Institute (US). Active surveillance for prostate cancer
  2. European Association of Urology. EAU Guidelines on Prostate Cancer
  3. National Cancer Institute (US). Follow-up medical care after cancer treatment
  4. ASCO (Cancer.Net). Survivorship
  5. Journal of Clinical Oncology (2023). Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update
  6. European Society for Medical Oncology. Cutaneous melanoma: ESMO Clinical Practice Guidelines